Drugs@FDA document
ALLOPURINOL Letter · NDA 018877 SUPPL-68
Drugs@FDA document · WATSON LABS · Apr 4, 2024
Key facts
| Drug name | ALLOPURINOL |
|---|---|
| Document type | Letter |
| Application | NDA018877 |
| Submission | SUPPL-68 |
| Company | WATSON LABS |
| Document date | Apr 4, 2024 |
At a glance
- Labeling-Package Insert Document categories
- 1–9 Documents for this application
- None USP chapters cited in this application's documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: